C14orf147 Activators
Chemical activators of C14orf147 engage with the protein through various signaling pathways, predominantly involving phosphorylation, a common post-translational modification that regulates protein activity. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which can phosphorylate a wide range of substrates. When PMA is introduced to cells, it can activate PKC, which may then target C14orf147 for phosphorylation, thereby altering its functional state. Forskolin operates through a different mechanism, activating adenylyl cyclase and consequently increasing cyclic AMP (cAMP) levels within the cell. The surge in cAMP can activate protein kinase A (PKA), which then can also phosphorylate C14orf147. Ionomycin, by increasing intracellular calcium levels, can trigger the activation of calmodulin-dependent kinases, potentially leading to the phosphorylation of C14orf147 if it is within their substrate specificity. Thapsigargin, by inhibiting SERCA, raises cytosolic calcium levels, possibly resulting in the activation of calcium-dependent kinases that may phosphorylate C14orf147.
Furthermore, the regulatory balance of phosphorylation is also influenced by the presence of phosphatase inhibitors, such as Calyculin A and Okadaic Acid. These compounds inhibit phosphatases like PP1 and PP2A, preventing the dephosphorylation and thus maintaining proteins, including C14orf147, in an activated state if they were previously phosphorylated. Anisomycin is another activator that induces the activation of stress-activated protein kinases, which might include kinases capable of phosphorylating C14orf147. Phosphatidylinositol 3,4,5-triphosphate (PIP3) is a lipid-derived secondary messenger that activates Akt kinase, a kinase that can phosphorylate a range of proteins, possibly including C14orf147. Epigallocatechin gallate (EGCG) increases cAMP levels by inhibiting phosphodiesterases, which leads to activation of PKA, potentially resulting in the phosphorylation of C14orf147. Lastly, Isoproterenol raises intracellular cAMP levels; it activates adenylyl cyclase via beta-adrenergic receptors, culminating in the activation of PKA which may target C14orf147 for phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC) which is known to phosphorylate a myriad of proteins. Since C14orf147 is a protein, the activation of PKC by PMA can lead to the phosphorylation and subsequent activation of C14orf147, given that PKC-mediated phosphorylation is a common mechanism for regulating protein function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. High calcium can activate calmodulin-dependent kinases, which are known to phosphorylate a wide range of proteins. The activation of these kinases by ionomycin can lead to the phosphorylation and activation of C14orf147 if it is a substrate for these kinases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels. This can activate calcium-dependent proteins and pathways, including kinases that could phosphorylate and activate C14orf147, assuming the protein is within their substrate range. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which prevents dephosphorylation of proteins. By inhibiting these phosphatases, Calyculin A can maintain proteins in their phosphorylated, and potentially activated, state. Thus, C14orf147 can remain activated if it is normally regulated by reversible phosphorylation and is a target for PP1 or PP2A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid is a potent inhibitor of protein phosphatases, particularly PP1 and PP2A. By inhibiting these enzymes, Okadaic Acid can lead to increased phosphorylation levels of proteins within the cell, potentially including C14orf147, leading to its activation if it is regulated by dephosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases, such as JNK and p38 MAP kinase, which can phosphorylate a broad spectrum of protein substrates. Through the activation of these kinases, anisomycin can contribute to the phosphorylation and activation of C14orf147 if it is a target for these kinases. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can inhibit phosphodiesterases, which leads to an increase in cAMP levels within the cell, thereby activating PKA. PKA, in turn, can phosphorylate and activate numerous proteins. If C14orf147 is a substrate for PKA, then EGCG can activate C14orf147 through this pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can activate adenylyl cyclase via beta-adrenergic receptors, leading to increased cAMP and activation of PKA. PKA can then phosphorylate various substrates, which could include C14orf147, resulting in its activation. | ||||||